← back to search

Omalkhair Abulkhair

Riyadh Armed Forces Hospital · SA
Area of research
Oncology · Cancer Research
Research interest
Research interests include Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Global Cancer Incidence and Screening, and BRCA gene mutations in cancer.
h-index
18
citations
1,659
works
48
NIH funding
primary concept
Medicine
email

Recent publications

ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)
Annals of Oncology 2022cited by 210position: middledoi
ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
Annals of Oncology 2020cited by 252position: middledoi
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)
The Breast 2017cited by 247position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Maria João Cardoso · IPO Porto3 papers (2017–2022)Ann H. Partridge · Harvard University3 papers (2017–2022)Elżbieta Senkus · European Institute of Oncology3 papers (2017–2022)Karen A. Gelmon · BC Cancer Agency3 papers (2017–2022)Olivia Pagani · Hôpital Riviera-Chablais3 papers (2017–2022)Giancarlo Pruneri · University of Milan3 papers (2017–2022)Tanja Španič · Alma Mater Europaea3 papers (2017–2022)Shani Paluch–Shimon · Hebrew University of Jerusalem3 papers (2017–2022)Fedro A. Peccatori · European Institute of Oncology3 papers (2017–2022)Fátima Cardoso · Banco de Portugal3 papers (2017–2022)Nadia Harbeck · Universität Bayern3 papers (2017–2022)Hatem A. Azim · Cairo University2 papers (2020–2022)J. Merschdorf · Young Survival Coalition2 papers (2020–2022)Giuseppe Curigliano · Istituti di Ricovero e Cura a Carattere Scientifico2 papers (2020–2022)Oreste ­Gentilini · Vita-Salute San Raffaele University2 papers (2017–2022)Philip Poortmans · Ziekenhuisnetwerk Antwerpen Stuivenberg2 papers (2020–2022)G. Bianchi-Micheli · Laboratory for Biomedical Neurosciences2 papers (2020–2022) · 1 papers (2017–2017)S.B. Kim · Ulsan College1 papers (2022–2022)Bella Kaufman · NYU Langone Health1 papers (2022–2022)